Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Wingard

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|December 27, 2005
Posaconazole as salvage therapy for zygomycosisR N Greenberg, K Mullane, J-A H van Burik, et al.
Bone Marrow Transplantation|August 18, 2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantationD J Winston, J H Antin, S N Wolff, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationM Tomblyn, M Chen, M Kukreja, et al.
Bone Marrow Transplantation|January 15, 2014
Clinical guide to fertility preservation in hematopoietic cell transplant recipientsS Joshi, B N Savani, E J Chow, et al.
Bone Marrow Transplantation|September 12, 2012
Second malignancies after autologous hematopoietic cell transplantation in childrenK E Danner-Koptik, N S Majhail, R Brazauskas, et al.
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
Bone Marrow Transplantation|February 20, 2013
Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipientsA W Loren, R Brazauskas, E J Chow, et al.
Bone Marrow Transplantation|December 4, 2003
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of ageD E Reece, C Bredeson, W S Pérez, et al.
Bone Marrow Transplantation|December 20, 2016
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR studyR T Maziarz, R Brazauskas, M Chen, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|December 27, 2005
Posaconazole as salvage therapy for zygomycosisR N Greenberg, K Mullane, J-A H van Burik, et al.
Bone Marrow Transplantation|August 18, 2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantationD J Winston, J H Antin, S N Wolff, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationM Tomblyn, M Chen, M Kukreja, et al.
Bone Marrow Transplantation|January 15, 2014
Clinical guide to fertility preservation in hematopoietic cell transplant recipientsS Joshi, B N Savani, E J Chow, et al.
Bone Marrow Transplantation|September 12, 2012
Second malignancies after autologous hematopoietic cell transplantation in childrenK E Danner-Koptik, N S Majhail, R Brazauskas, et al.
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
Bone Marrow Transplantation|February 20, 2013
Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipientsA W Loren, R Brazauskas, E J Chow, et al.
Bone Marrow Transplantation|December 4, 2003
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of ageD E Reece, C Bredeson, W S Pérez, et al.
Bone Marrow Transplantation|December 20, 2016
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR studyR T Maziarz, R Brazauskas, M Chen, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
Pageof 18